Search clinical trials for: Aripiprazole, olanzapine and risperidone (Antipsychotics)

Total 2634 results

Solvay Pharmaceuticals
Wyeth is now a wholly owned subsidiary of Pfizer; H. Lundbeck A/S

Completed

Switch Study of Existing Atypical Antipsychotics to Bifeprunox

Schizophrenia and Schizoaffective Disorder

Hungary, United States, Argentina, Canada, Czech Republic, Estonia, France, Latvia, Lithuania
FDA Office of Orphan Products Development
National Institute of Mental Health (NIMH)

Completed

A Controlled Study of Olanzapine in Children With Autism

Autistic Disorder

United States
Northwell Health
National Institute of Mental Health (NIMH); The Zucker Hillside Hospital

Completed

Treatment for First-Episode Schizophrenia

Schizophrenia

United States
Otsuka Pharmaceutical Co., Ltd.

Completed

Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive Disorder

Major Depressive Disorder

Japan
Otsuka Pharmaceutical Development & Commercialization...

Terminated

A Trial to Measure the Difference in All-cause Hospitalizations for Participants Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder

Schizophrenia | Major Depressive Disorder | Bipolar 1 Disorder

United States
Beijing HuiLongGuan Hospital

Completed

A Randomized Double-blind Trial With 6 Antipsychotic Drugs for Schizophrenia

Schizophrenia

China
Amani Hassan Abdel-Wahab

Completed

Olanzapine for the Prevention of Postoperative Nausea and Vomiting

Postoperative Nausea

Egypt
The Mind Research Network

Completed

A New Pharmacotherapy for Alcohol Dependence: Olanzapine

Alcohol Dependence

United States
Eli Lilly and Company

Completed

Comparing the Effect of Under the Tongue Olanzapine Versus Swallowed Olanzapine on Body Mass Index (A Ratio of Weight to Height)

Schizophrenia | Schizoaffective Disorder | Bipolar Disorder

United States, Puerto Rico, Netherlands, Canada, Mexico
H. Lundbeck A/S
Otsuka Pharmaceutical Co., Ltd.

Completed

Aripiprazole Once-monthly Versus Paliperidone Palmitate in Adult Patients With Schizophrenia

Schizophrenia

United States
Shanxi Medical University

Unknown

The Role of miR-30 Family Dysregulation in Response to Antipsychotic Treatment

Schizophrenia

China
University of California, Los Angeles
Alkermes, Inc.

Terminated

Aripiprazole Lauroxil for Preventing Psychotic Relapse After an Initial Schizophrenia Episode (APPRAISE)

Schizophrenia | Schizophreniform Disorder | Schizoaffective Disorder, Depressive Type

United States
Rovi Pharmaceuticals Laboratories

Completed

Comparative Bioavailability of Risperidone

Schizophrenia

United States
Indivior Inc.

Completed

Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetic/Efficacy

Schizophrenia

United States
Janssen-Cilag Ltd.

Completed

Switching From Oral Antipsychotics to Long-Acting Risperidone in Participants With Schizophrenia

Schizophrenia

Brazil
Janssen Pharmaceutica N.V., Belgium

Completed

A Study of the Safety and Effectiveness of Risperidone for the Treatment of Conduct Disorder and Other Disruptive Behavior Disorders in Children Ages 5 to 12 With Mild, Moderate, or Borderline Mental Retardation

Conduct Disorder | Oppositional Defiant Disorder | Disruptive Behavior Disorder
Hospital Authority, Hong Kong
Janssen Pharmaceutica N.V., Belgium

Unknown

Evaluation of Efficacy and Safety of Long-acting Risperidone Microspheres in Patients With Schizophrenia or Other Psychotic Disorders When Switching From Typical Antipsychotic (Oral/Depot) or Atypical Oral Other Than Risperidone

Psychotic Disorders | Schizophrenia | Schizophrenia, Paranoid | Schizophrenia, Catatonic | Schizophrenia, Disorganized

China
University of California, Los Angeles
National Institute of Mental Health (NIMH); Janssen Scientific Affairs, LLC

Completed

Psychosocial Therapy and Risperidone Treatment in Work Performance in Recent-Onset Schizophrenia

Schizophrenia

United States
AstraZeneca

Completed

Safety and Efficacy of Seroquel in First Episode Schizophrenia

Schizophrenia

United Kingdom
Indivior Inc.

Completed

Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients

Schizophrenia

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Pharmacokinetic Study of Risperidone and Topiramate Administered Alone and in Combination in Patients With Bipolar Disorder or Schizoaffective Disorders

Bipolar Disorder
Janssen, LP

Completed

A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol in Patients With Chronic Schizophrenia

Schizophrenia | Psychotic Disorder
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Effectiveness and Safety of Risperidone as add-on Therapy to Mood Stabilizers in the Treatment of Manic Episodes Associated With Bipolar Disorder

Bipolar Disorders | Manic Disorder
Rush University Medical Center
Janssen, LP

Terminated

Treatment of Major Depressive Disorder With Psychotic Features.

Major Depression With Psychotic Features

United States
Erasmus Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development; Stichting...

Recruiting

Safety and Pharmacokinetics of Antipsychotics in Children 2: Studying TDM in an RCT (SPACe2:STAR)

Autism Spectrum Disorder

Netherlands
Janssen, LP

Completed

Observational Study in Patients With Schizophrenia Treated With Long-Acting Risperidone Injection (RISPERDAL CONSTA) (SOURCE)

Schizophrenia

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Comparison of the Pharmacokinetics and Safety of Long-acting Injectable Risperidone When Administered to Gluteal or Deltoid Intramuscular Injection Sites in Stable Schizophrenia Patients.

Schizophrenia
Janssen Pharmaceutica N.V., Belgium

Completed

RiSPECT: Risperdal Safety Protocol Evaluation Consta Treatment, a Post Authorization Safety Survey to Obtain Information on the Safety and Efficacy of Risperidone When Used in Routine Clinical Practice

Psychotic Disorders | Schizophrenia | Schizoaffective Disorder
Alkermes, Inc.

Completed

An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia

Schizophrenia

United States
Johnson & Johnson Taiwan Ltd

Terminated

A Study to Evaluate the Effect of Oral Paliperidone Extended-Release and Oral Risperidone Immediate-Release on Cognitive Function in Clinically Stable Patients With Schizophrenia

Schizophrenia

Taiwan
Fundación Marques de Valdecilla
Centro de Investigación Biomédica en Red de Salud Mental; Instituto de Investigación...

Unknown

Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 3-years Follow-up (PAFIP3_nc3Y)

Psychotic Disorders | Schizophrenia | Psychosis

Spain
Taiwan Otsuka Pharm. Co., Ltd

Completed

Aripiprazole in the Treatment of Acutely Relapsed Patients With Schizophrenia

Schizophrenia | Schizoaffective Disorder

Taiwan
Seattle Institute for Biomedical and Clinical Research
Eli Lilly and Company

Active, not recruiting

Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine

Obesity | Schizophrenia | Schizoaffective Disorder | Metabolic Syndrome | Bipolar Disorder

United States
University of Illinois at Chicago

Completed

Risperidone and Divalproex Sodium With MRI Assessment in Pediatric Bipolar

Bipolar Disorder

United States
Ottawa Hospital Research Institute

Completed

Individualised Versus Standard Care for Breast Cancer Patients at High-risk for Chemotherapy-induced Nausea and Vomiting The ILIAD Study

Breast Cancer

Canada
Eli Lilly and Company

Completed

A Study Comparing Rapid Acting Intramuscular Olanzapine and Placebo in Agitated Patients With Schizophrenia

Schizophrenia

Japan
Centre for Addiction and Mental Health
University Health Network, Toronto

Recruiting

Intranasal Insulin and Olanzapine Study in Healthy Volunteers (INI/OLA)

Healthy Controls

Canada
Dr Rabia Arshad

Completed

Synergistic Effect of Vitamin E & D in Reducing Risk of Effects Associated With Atypical Anti-psychotics

Antipsychotics and Neuroleptics Toxicity

Pakistan
Fundación Marques de Valdecilla
Centro de Investigación Biomédica en Red de Salud Mental; Instituto de Investigación...

Unknown

Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 3-year Follow-up (PAFIP3_3Y)

Psychotic Disorders | Schizophrenia | Psychosis

Spain
University of British Columbia
Vancouver Coastal Health

Unknown

Comparison of Aripiprazole Versus Risperidone on Brain Morphology Using MRI (CARB)

Bipolar Disorder | First-Episode Psychosis

Canada
Rovi Pharmaceuticals Laboratories

Completed

Comparative Bioavailability of Risperidone.

Schizophrenia

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Effectiveness and Safety of Risperidone Compared With Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder, and the Maintenance of Anti-manic Effectiveness of Risperidone Compared With Haloperidol

Bipolar Disorders | Manic Disorder
Kaohsiung Kai-Suan Psychiatric Hospital

Terminated

Comparison of the Efficacy and Safety of Risperidone Versus Risperidone Plus Low Dose of Haloperidol in the Treatment of Schizophrenia

Schizophrenia

Taiwan
Inje University

Terminated

Quality of Life (QOL) in Female Patient With Schizophrenia

Schizophrenia

Korea, Republic of
Seattle Institute for Biomedical and Clinical Research
Janssen, LP

Completed

A Trial of Long-Acting Injectable Risperidone in the Treatment of Methamphetamine Dependence

Methamphetamine Dependence

United States
Otsuka Pharmaceutical Co., Ltd.

Completed

A Short Treatment Study of Aripiprazole in Pediatric Patients With Schizophrenia

Schizophrenia

Japan
Deborah Yurgelun-Todd
Otsuka America Pharmaceutical

Completed

Study of the Impact of Aripiprazole (Abilify®) Once Monthly Versus Standard of Care Oral Antipsychotic Medications on Changes in Brain Structure and Metabolism

Schizophrenia

United States
Central Institute of Mental Health, Mannheim
Ludwig-Maximilians - University of Munich; Heidelberg University; Technical University... and other collaborators

Active, not recruiting

A Four-week Clinical Trial Investigating Efficacy and Safety of Cannabidiol as a Treatment for Acutely Ill Schizophrenic Patients

Schizophrenia

Germany, Denmark
Dartmouth-Hitchcock Medical Center
National Institute of Mental Health (NIMH)

Completed

First Episode Schizophrenia and Cannabis-Related Disorder Study

Substance-Related Disorders | Psychotic Disorders | Schizophrenia | Cannabis-Related Disorder

United States
Merck Sharp & Dohme LLC

Completed

An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)

Schizophrenia, Acute Episode

United States

Search clinical trials for: Aripiprazole, olanzapine and risperidone (Antipsychotics)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Montenegro

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations